Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plcverified

HOPHF

Price:

$2.33

Market Cap:

$27.81M

Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal H...[Read more]

Industry

Biotechnology

IPO Date

2021-01-12

Stock Exchange

OTC

Ticker

HOPHF

The Enterprise Value as of December 2025 (TTM) for Hemogenyx Pharmaceuticals Plc (HOPHF) is 30.28M

According to Hemogenyx Pharmaceuticals Plc’s latest financial reports and current stock price. The company's current Enterprise Value is 30.28M. This represents a change of 54.53% compared to the average of 19.59M of the last 4 quarters.

Hemogenyx Pharmaceuticals Plc (HOPHF) Historical Enterprise Value (quarterly & annually)

How has HOPHF Enterprise Value performed in the past?

The mean historical Enterprise Value of Hemogenyx Pharmaceuticals Plc over the last ten years is 644.00M. The current 30.28M Enterprise Value has changed 370.15% with respect to the historical average. Over the past ten years (40 quarters), HOPHF's Enterprise Value was at its highest in in the June 2017 quarter at 3.43B. The Enterprise Value was at its lowest in in the August 2014 quarter at 0.

Quarterly (TTM)
Annual

Average

644.00M

Median

14.88M

Minimum

4.63M

Maximum

5.34B

Hemogenyx Pharmaceuticals Plc (HOPHF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Hemogenyx Pharmaceuticals Plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 447.26%

Maximum Annual Enterprise Value = 5.34B

Minimum Annual Increase = -99.91%

Minimum Annual Enterprise Value = 4.63M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202415.83M-42.77%
202327.67M98.76%
202213.92M80.33%
20217.72M-80.63%
202039.85M411.35%
20197.79M11.75%
20186.97M50.60%
20174.63M-99.91%
20165.34B447.26%
2015975.75M7.39%

Hemogenyx Pharmaceuticals Plc (HOPHF) Average Enterprise Value

How has HOPHF Enterprise Value performed in the past?

The current Enterprise Value of Hemogenyx Pharmaceuticals Plc (HOPHF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

19.14M

5-year avg

21.00M

10-year avg

644.00M

Hemogenyx Pharmaceuticals Plc (HOPHF) Enterprise Value vs. Peers

How is HOPHF’s Enterprise Value compared to its peers?

Hemogenyx Pharmaceuticals Plc’s Enterprise Value is greater than Kiromic BioPharma, Inc. (13.65M), less than TuHURA Biosciences, Inc. (94.34M), greater than Vitalibis, Inc. (1.32M), greater than Advanced Proteome Therapeutics Corporation (-63027.00), greater than CuraScientific Corp (3.01M), greater than Evome Medical Technologies Inc. (19.72M), less than ProSomnus, Inc. (42.48M), less than Pivotal Therapeutics Inc. (0), greater than TRACON Pharmaceuticals, Inc. (-7486275.00), greater than Predictive Technology Group, Inc. (7.60M),

Build a custom stock screener for Hemogenyx Pharmaceuticals Plc (HOPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hemogenyx Pharmaceuticals Plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hemogenyx Pharmaceuticals Plc (HOPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hemogenyx Pharmaceuticals Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Hemogenyx Pharmaceuticals Plc's Enterprise Value?

What is the highest Enterprise Value for Hemogenyx Pharmaceuticals Plc (HOPHF)?

What is the 3-year average Enterprise Value for Hemogenyx Pharmaceuticals Plc (HOPHF)?

What is the 5-year average Enterprise Value for Hemogenyx Pharmaceuticals Plc (HOPHF)?

How does the current Enterprise Value for Hemogenyx Pharmaceuticals Plc (HOPHF) compare to its historical average?